• 1
    El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S2734.
  • 2
    Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 190717.
  • 3
    Abe K, Edamoto Y, Park YN et al. In situ detection of hepatitis B, C, and G virus nucleic acids in human hepatocellular carcinoma tissues from different geographic regions. Hepatology 1998; 28: 56872.
  • 4
    Kao JH, Chen DS. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int 2005; 25: 696703.
  • 5
    Chisari FV. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol 2000; 156: 111732.
  • 6
    Bréchot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127: S5661.
  • 7
    Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 1999; 179: 77582.
  • 8
    Huy TT, Ushijima H, Quang VX et al. Characteristics of core promoter and precore stop codon mutants of hepatitis B virus in Vietnam. J Med Virol 2004; 74: 22836.
  • 9
    Chen CH, Lee CM, Lu SN et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol 2005; 43: 60006.
  • 10
    Huy TT, Ushijima H, Win KM et al. High prevalence of hepatitis B virus pre-S mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 2003; 41: 544955.
  • 11
    Chen BF, Liu CJ, Jow GM et al. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 2006; 130: 115368.
  • 12
    Lin CL, Liu CH, Chen W et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 2007; 22: 1098103.
  • 13
    Zhang KY, Imazeki F, Fukai K et al. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma. Cancer Sci 2007; 98: 19219.
  • 14
    Chen CH, Hung CH, Lee CM et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 2007; 133: 146674.
  • 15
    Wang HC, Wu HC, Chen CF et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 2003; 163: 24419.
  • 16
    Hsieh YH, Su IJ, Wang HC et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004; 25: 202332.
  • 17
    Wang HC, Huang W, Lai MD, Su IJ. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 2006; 97: 6838.
  • 18
    Su IJ, Wang HC, Wu HC, Huang WY. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J Gastroenterol Hepatol 2008; 23: 116974.
  • 19
    Hildt E, Saher G, Bruss V, Hofschneider PH. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virol 1996; 225: 2359.
  • 20
    Kim HS, Ryu CJ, Hong HJ. Hepatitis B virus preS1 functions as a transcriptional activation domain. J Gen Virol 1997; 78: 10836.
  • 21
    Ni YH, Chang MH, Hsu HY et al. Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 1991; 68: 173741.
  • 22
    Reynolds M. Pediatric liver tumors. Semin Surg Oncol 1999; 16: 15972.
  • 23
    Nakajima A, Usui M, Huy TT et al. Full-length sequence of hepatitis B virus belonging to genotype H identified in a Japanese patient with chronic hepatitis. Jpn J Infect Dis 2005; 58: 2446.
  • 24
    Tanaka T, Miyamoto H, Hino O et al. Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy. Hum Pathol 1986; 17: 2024.
  • 25
    Tsuei DJ, Chang MH, Chen PJ, Hsu TY, Ni YH. Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas. J Med Virol 2002; 68: 51321.
  • 26
    Chen CL, Yang HI, Yang WS et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 11121.
  • 27
    Wang LY, You SL, Lu SN et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003; 14: 24150.
  • 28
    Yeh FS, Yu MC, Mo CC et al. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res 1989; 49: 25069.
  • 29
    Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338: 13569.
  • 30
    Ni YH, Chang MH, Wang KJ et al. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 2004; 127: 17338.
  • 31
    Wang JD, Chang TK, Chen HC et al. Pediatric liver tumors: initial presentation, image finding and outcome. Pediatr Int 2007; 49: 4916.
  • 32
    Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 18559.
  • 33
    Broderick AL, Jonas MM. Hepatitis B in children. Semin Liver Dis 2003; 23: 5968.
  • 34
    Mimms L. Hepatitis B virus escape mutants: “pushing the envelope” of chronic hepatitis B virus infection. Hepatology 1995; 21: 8847.
  • 35
    Tai PC, Banik D, Lin GI et al. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol 1997; 71: 48526.
  • 36
    Melegari M, Bruno S, Wands JR. Properties of hepatitis B virus pre-S1 deletion mutants. Virol 1994; 199: 292300.
  • 37
    Melegari M, Scaglioni PP, Wands JR. The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted. J Virol 1997; 71: 544954.
  • 38
    Wands J. Hepatocellular carcinoma and sex. N Engl J Med 2007; 357: 19746.
  • 39
    Naugler WE, Sakurai T, Kim S et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 1214.
  • 40
    Jie X, Lang C, Jian Q et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 2007; 26: 574151.